OPDIVO 10 mg/mL concentrate for solution for infusion.
CSET N°2018/2706
Phase 2 small_molecule active
Quick answer
OPDIVO 10 mg/mL concentrate for solution for infusion. for Relapsing/Refractory ALK+ Anaplastic Large cell Lymphoma is a Phase 2 program (small_molecule) at Institut für biomedizinische Analytik NMR-Imaging GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Institut für biomedizinische Analytik NMR-Imaging GmbH
- Indication
- Relapsing/Refractory ALK+ Anaplastic Large cell Lymphoma
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active